Stay updated on Ledipasvir/Sofosbuvir in Chronic Genotype 1 HCV Clinical Trial
Sign up to get notified when there's something new on the Ledipasvir/Sofosbuvir in Chronic Genotype 1 HCV Clinical Trial page.

Latest updates to the Ledipasvir/Sofosbuvir in Chronic Genotype 1 HCV Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be a general site version upgrade with no observable changes to study details or data fields.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 was removed.SummaryDifference0.0%

- Check60 days agoChange Detected- Added Revision: v3.4.2 and removed Revision: v3.4.1.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page update reflects a revision from v3.4.0 to v3.4.1 and does not alter study content or essential features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check89 days agoChange DetectedRevision has been updated from v3.3.3 to v3.3.4, a minor metadata change with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check111 days agoChange DetectedAdded a new Locations section with Gyeonggi-do listed as a location. Removed the HHS Vulnerability Disclosure and the Gyeonggi-do Locations section.SummaryDifference0.2%

Stay in the know with updates to Ledipasvir/Sofosbuvir in Chronic Genotype 1 HCV Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ledipasvir/Sofosbuvir in Chronic Genotype 1 HCV Clinical Trial page.